Skip to main content

NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Investor Securities Class Action Lawsuit 01/18/2022

  • If you purchased a significant amount of shares of NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) between June 1, 2021 and November 4, 2021, and / or if you purchased any NASDAQ: NRXP shares prior to June 2021 and continue to hold any of those shares, you have certain options and for certain investors are short and strict deadlines running. Deadline: March 21, 2022. NASDAQ: NRXP investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

January 18, 2022 - An investor in shares of NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) filed a lawsuit in the U.S. District Court for the District of Delaware over alleged violations of Federal Securities Laws by NRx Pharmaceuticals, Inc. in connection with certain allegedly false and misleading statements made between June 1, 2021 and November 4, 2021. Wilmington, DE based NRX Pharmace...

You must register (for free) or login to view the entire case.